Clinical Trial Update: A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of namilumab (MT203) in patients with mild to moderate rheumatoid arthritis; the study completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Namilumab (namilumab)

Snippet

Sponsor: Takeda | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2015-08-20